N/A
N=74
Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents
Advanced Cancer · Relapsed Cancer · Refractory Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04310345 ↗Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcome: Primary: Pediatric Quality of Life — 47.6; 50.3; 61.6; 41.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Animal-Assisted Interactions (Behavioral)
- Age
- Pediatric, Adult, Older Adult · 6+ yrs
- Sex
- All
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Primary completion
- Feb 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pediatric Quality of Life |
47.6; 50.3; 61.6; 41.5; 37.8; 47.8 | — |
| PRIMARY Anxiety |
31.4; 29.2; 29.5; 40.2; 35.6; 35.9 | — |
Summary
This study will evaluate the effects of human-animal interaction on reducing anxiety, depression, worry, and pain and enhancing quality of life in children ages 6-17 years old with a life threatening cancer and their parent caregivers.
Eligibility Criteria
Inclusion Criteria
Child:
- Children age 6-17 years old that have been diagnosed with advanced cancer as defined by any stage of relapsed, recurrent or refractory cancer
- Able to understand English or Spanish to complete consents and surveys
Parent or Guardian:
- Parent or guardian as determined by person who brings child to >50% of their clinic visits
- Able to understand English or Spanish to complete consents and surveys
Exclusion Criteria for both Children and Parent/Guardian:
- Self-reported fear of or allergies to canines
- Cognitive impairment as identified by healthcare team or inability to complete consenting process
Data sourced from ClinicalTrials.gov (NCT04310345). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.